Cite
Bäck S, Peränen J, Galli E, et al. Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease. Brain Behav. 2013;3(2):75-88doi: 10.1002/brb3.117.
Bäck, S., Peränen, J., Galli, E., Pulkkila, P., Lonka-Nevalaita, L., Tamminen, T., Voutilainen, M. H., Raasmaja, A., Saarma, M., Männistö, P. T., & Tuominen, R. K. (2013). Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease. Brain and behavior, 3(2), 75-88. https://doi.org/10.1002/brb3.117
Bäck, Susanne, et al. "Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease." Brain and behavior vol. 3,2 (2013): 75-88. doi: https://doi.org/10.1002/brb3.117
Bäck S, Peränen J, Galli E, Pulkkila P, Lonka-Nevalaita L, Tamminen T, Voutilainen MH, Raasmaja A, Saarma M, Männistö PT, Tuominen RK. Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease. Brain Behav. 2013 Mar;3(2):75-88. doi: 10.1002/brb3.117. Epub 2013 Jan 14. PMID: 23532969; PMCID: PMC3607149.
Copy
Download .nbib